i2 Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

i2 Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company intended to provide cancer treatment. The company's Cancer therapeutics is mainly focused on small molecules, antibody and antibody like compounds, enabling medical industry to obtain therapeutics for cancer treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4909 Nautilus Court North
  • Suite 208
  • Boulder, CO 80301
  • United States
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 4909 Nautilus Court North
  • Suite 208
  • Boulder, CO 80301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

i2 Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore i2 Pharmaceuticals‘s full profile, request access.

Request a free trial

i2 Pharmaceuticals Patents

i2 Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018126176-A1 Synthetic guide molecules, compositions and methods relating thereto Inactive 30-Dec-2016
US-10858448-B2 Anti-surrogate light chain antibodies Active 02-Feb-2015
US-20180265594-A1 Anti-surrogate light chain antibodies Active 02-Feb-2015
AU-2017254895-A1 Binding molecule conjugates Active 20-Jan-2012
AU-2017254895-B2 Binding molecule conjugates Inactive 20-Jan-2012 A61K31/5383
To view i2 Pharmaceuticals’s complete patent history, request access »

i2 Pharmaceuticals Investments (1)

i2 Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Sea Lane Biotechnologies (Antibody and Protein Engineering Technology Portfolio). The deal was made on 30-May-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sea Lane Biotechnologies (Antibody and Protein Engineering Technology Portfolio) 30-May-2017 Corporate Asset Purchase Buildings and Property
To view i2 Pharmaceuticals’s complete investments history, request access »

i2 Pharmaceuticals FAQs

  • When was i2 Pharmaceuticals founded?

    i2 Pharmaceuticals was founded in 2014.

  • Where is i2 Pharmaceuticals headquartered?

    i2 Pharmaceuticals is headquartered in Boulder, CO.

  • What industry is i2 Pharmaceuticals in?

    i2 Pharmaceuticals’s primary industry is Drug Discovery.

  • Is i2 Pharmaceuticals a private or public company?

    i2 Pharmaceuticals is a Private company.

  • What is the current valuation of i2 Pharmaceuticals?

    The current valuation of i2 Pharmaceuticals is .

  • What is i2 Pharmaceuticals’s current revenue?

    The current revenue for i2 Pharmaceuticals is .

  • When was i2 Pharmaceuticals acquired?

    i2 Pharmaceuticals was acquired on 22-Jan-2018.

  • Who acquired i2 Pharmaceuticals?

    i2 Pharmaceuticals was acquired by Editas Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process